Recent advances and challenges in antibacterial drug development: Editorial.
作者信息
Silver Lynn
机构信息
LL Silver Consulting, New Jersey, United States;
出版信息
ADMET DMPK. 2022 Mar 4;10(2):89-90. doi: 10.5599/admet.1315. eCollection 2022.
Abstract
摘要
相似文献
1
Recent advances and challenges in antibacterial drug development: Editorial.
ADMET DMPK. 2022 Mar 4;10(2):89-90. doi: 10.5599/admet.1315. eCollection 2022.
2
Recent advances and challenges in antibacterial drug development.
ADMET DMPK. 2022 Mar 4;10(2):147-151. doi: 10.5599/admet.1271. eCollection 2022.
3
Protein-Based Systems for Topical Antibacterial Therapy.
Front Med Technol. 2021 Jun 24;3:685686. doi: 10.3389/fmedt.2021.685686. eCollection 2021.
4
Advances of peptides for antibacterial applications.
Colloids Surf B Biointerfaces. 2021 Jun;202:111682. doi: 10.1016/j.colsurfb.2021.111682. Epub 2021 Mar 8.
5
Antibacterial applications of graphene-based nanomaterials: Recent achievements and challenges.
Adv Drug Deliv Rev. 2016 Oct 1;105(Pt B):176-189. doi: 10.1016/j.addr.2016.04.009. Epub 2016 Apr 27.
6
Advances in preparation and application of antibacterial hydrogels.
J Nanobiotechnology. 2023 Aug 26;21(1):300. doi: 10.1186/s12951-023-02025-8.
7
Recent advances on nanomaterials for antibacterial treatment of oral diseases.
Mater Today Bio. 2023 Apr 15;20:100635. doi: 10.1016/j.mtbio.2023.100635. eCollection 2023 Jun.
8
Antibacterial Coatings: Challenges, Perspectives, and Opportunities.
Trends Biotechnol. 2015 Nov;33(11):637-652. doi: 10.1016/j.tibtech.2015.09.002. Epub 2015 Oct 14.
9
Antibacterial gas therapy: Strategies, advances, and prospects.
Bioact Mater. 2022 Nov 11;23:129-155. doi: 10.1016/j.bioactmat.2022.10.008. eCollection 2023 May.
10
Mg-, Zn-, and Fe-Based Alloys With Antibacterial Properties as Orthopedic Implant Materials.
Front Bioeng Biotechnol. 2022 May 23;10:888084. doi: 10.3389/fbioe.2022.888084. eCollection 2022.
引用本文的文献
1
Antimicrobial Resistance Profile of Isolated From Hospital and Industrial Wastewater Systems.
Environ Health Insights. 2025 May 31;19:11786302251339254. doi: 10.1177/11786302251339254. eCollection 2025.
2
Understanding bacterial pathogenicity: a closer look at the journey of harmful microbes.
Front Microbiol. 2024 Feb 20;15:1370818. doi: 10.3389/fmicb.2024.1370818. eCollection 2024.
3
Procalcitonin-Based Antibiotic Use for Neonatal Early-Onset Bacterial Infections: Pre- and Post-Intervention Clinical Study.
Antibiotics (Basel). 2023 Sep 9;12(9):1426. doi: 10.3390/antibiotics12091426.
本文引用的文献
1
Newly discovered serine hydrolase probe and drug targets.
ADMET DMPK. 2021 Oct 28;10(2):107-114. doi: 10.5599/admet.1137. eCollection 2022.
2
Impact of host factors on susceptibility to antifungal agents.
ADMET DMPK. 2022 Jan 7;10(2):153-162. doi: 10.5599/admet.1164. eCollection 2022.
3
Realistic and critical review of the state of systemic antimicrobial peptides.
ADMET DMPK. 2022 Jan 20;10(2):91-105. doi: 10.5599/admet.1215. eCollection 2022.
4
Recent advances and challenges in antibacterial drug development.
ADMET DMPK. 2022 Mar 4;10(2):147-151. doi: 10.5599/admet.1271. eCollection 2022.
5
Old and modern antibiotic structures with potential for today's infections.
ADMET DMPK. 2022 Mar 4;10(2):131-146. doi: 10.5599/admet.1272. eCollection 2022.
6
Recent advances in nanoparticles as antibacterial agent.
ADMET DMPK. 2022 Feb 2;10(2):115-129. doi: 10.5599/admet.1172. eCollection 2022.
7
Synthesis and diverse biological activity profile of triethylammonium isatin-3-hydrazones.
ADMET DMPK. 2022 Jan 12;10(2):163-179. doi: 10.5599/admet.1179. eCollection 2022.
8
The global preclinical antibacterial pipeline.
Nat Rev Microbiol. 2020 May;18(5):275-285. doi: 10.1038/s41579-019-0288-0. Epub 2019 Nov 19.
9
Analysis of the clinical antibacterial and antituberculosis pipeline.
Lancet Infect Dis. 2019 Feb;19(2):e40-e50. doi: 10.1016/S1473-3099(18)30513-9. Epub 2018 Oct 15.
10
Challenges of antibacterial discovery.
Clin Microbiol Rev. 2011 Jan;24(1):71-109. doi: 10.1128/CMR.00030-10.
Zotero 插件